-
1
-
-
0017162163
-
Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group
-
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 33:451-458
-
(1976)
Br J Haematol
, vol.33
, pp. 451-458
-
-
Bennett, J.M.1
Catovsky, D.2
Daniel, M.T.3
Flandrin, G.4
Galton, D.A.5
Gralnick, H.R.6
Sultan, C.7
-
2
-
-
0018981189
-
A variant form of hypergranular promyelocytic leukemia (M3)
-
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1980) A variant form of hypergranular promyelocytic leukemia (M3). Ann Intern Med 92:261
-
(1980)
Ann Intern Med
, vol.92
, pp. 261
-
-
Bennett, J.M.1
Catovsky, D.2
Daniel, M.T.3
Flandrin, G.4
Galton, D.A.5
Gralnick, H.R.6
Sultan, C.7
-
3
-
-
0021345113
-
Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia
-
Larson RA, Kondo K, Vardiman JW, Butler AE, Golomb HM, Rowley JD (1984) Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. Am J Med 76:827-841
-
(1984)
Am J Med
, vol.76
, pp. 827-841
-
-
Larson, R.A.1
Kondo, K.2
Vardiman, J.W.3
Butler, A.E.4
Golomb, H.M.5
Rowley, J.D.6
-
4
-
-
0025875679
-
The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR
-
de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A (1991) The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675-684
-
(1991)
Cell
, vol.66
, pp. 675-684
-
-
de The, H.1
Lavau, C.2
Marchio, A.3
Chomienne, C.4
Degos, L.5
Dejean, A.6
-
5
-
-
0025780876
-
Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML
-
Kakizuka A, Miller WH Jr, Umesono K, Warrell RP Jr, Frankel SR, Murty VV, Dmitrovsky E, Evans RM (1991) Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66:663-674
-
(1991)
Cell
, vol.66
, pp. 663-674
-
-
Kakizuka, A.1
Miller Jr, W.H.2
Umesono, K.3
Warrell Jr, R.P.4
Frankel, S.R.5
Murty, V.V.6
Dmitrovsky, E.7
Evans, R.M.8
-
6
-
-
12344256672
-
Meeting report. Acute promyelocytic leukemia-associated coagulopathy, 21 January 2004, London, United Kingdom
-
Tallman MS, Brenner B, Serna JdL, Dombret H, Falanga A, Kwaan HC, Liebman H, Raffoux E, Rickles FR (2005) Meeting report. Acute promyelocytic leukemia-associated coagulopathy, 21 January 2004, London, United Kingdom. Leuk Res 29:347-351
-
(2005)
Leuk Res
, vol.29
, pp. 347-351
-
-
Tallman, M.S.1
Brenner, B.2
Serna, J.L.3
Dombret, H.4
Falanga, A.5
Kwaan, H.C.6
Liebman, H.7
Raffoux, E.8
Rickles, F.R.9
-
7
-
-
0032934735
-
The thrombophilic state in acute promyelocytic leukemia
-
Tallman MS (1999) The thrombophilic state in acute promyelocytic leukemia. Semin Thromb Hemost 25:209-215
-
(1999)
Semin Thromb Hemost
, vol.25
, pp. 209-215
-
-
Tallman, M.S.1
-
8
-
-
0015605395
-
Acute promyelocytic leukemia: Results of treatment by daunorubicin
-
Bernard J, Weil M, Boiron M, Jacquillat C, Flandrin G, Gemon MF (1973) Acute promyelocytic leukemia: results of treatment by daunorubicin. Blood 41:489-496
-
(1973)
Blood
, vol.41
, pp. 489-496
-
-
Bernard, J.1
Weil, M.2
Boiron, M.3
Jacquillat, C.4
Flandrin, G.5
Gemon, M.F.6
-
9
-
-
0023119073
-
Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia?
-
Goldberg MA, Ginsburg D, Mayer RJ, Stone RM, Maguire M, Rosenthal DS, Antin JH (1987) Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia? Blood 69:187-191
-
(1987)
Blood
, vol.69
, pp. 187-191
-
-
Goldberg, M.A.1
Ginsburg, D.2
Mayer, R.J.3
Stone, R.M.4
Maguire, M.5
Rosenthal, D.S.6
Antin, J.H.7
-
11
-
-
0023865201
-
Acute promyelocytic leukemia. Therapy results and prognostic factors
-
Sanz MA, Jarque I, Martin G, Lorenzo I, Martinez J, Rafecas J, Pastor E, Sayas MJ, Sanz G, Gomis F (1988) Acute promyelocytic leukemia. Therapy results and prognostic factors. Cancer 61:7-13
-
(1988)
Cancer
, vol.61
, pp. 7-13
-
-
Sanz, M.A.1
Jarque, I.2
Martin, G.3
Lorenzo, I.4
Martinez, J.5
Rafecas, J.6
Pastor, E.7
Sayas, M.J.8
Sanz, G.9
Gomis, F.10
-
12
-
-
0024519006
-
Acute promyelocytic leukemia: Treatment results during a decade at Memorial Hospital
-
Cunningham I, Gee TS, Reich LM, Kempin SJ, Naval AN, Clarkson BD (1989) Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital. Blood 73:1116-1122
-
(1989)
Blood
, vol.73
, pp. 1116-1122
-
-
Cunningham, I.1
Gee, T.S.2
Reich, L.M.3
Kempin, S.J.4
Naval, A.N.5
Clarkson, B.D.6
-
13
-
-
0025771289
-
A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemia
-
Fenaux P, Tertian G, Castaigne S, Tilly H, Leverger G, Guy H, Bordessoule D, Leblay R, Le Gall E, Colombat P, et al (1991) A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemia. J Clin Oncol 9:1556-1561
-
(1991)
J Clin Oncol
, vol.9
, pp. 1556-1561
-
-
Fenaux, P.1
Tertian, G.2
Castaigne, S.3
Tilly, H.4
Leverger, G.5
Guy, H.6
Bordessoule, D.7
Leblay, R.8
Le Gall, E.9
Colombat, P.10
-
14
-
-
0025865947
-
Treatment of acute promyelocytic leukemia with alltrans retinoic acid
-
Fenaux P, Degos L (1991) Treatment of acute promyelocytic leukemia with alltrans retinoic acid. Leuk Res 15:655-657
-
(1991)
Leuk Res
, vol.15
, pp. 655-657
-
-
Fenaux, P.1
Degos, L.2
-
15
-
-
0021698664
-
Acute promyelocytic leukemia: Retrospective study of 119 patients treated with daunorubicin (in French)
-
Marty M, Ganem G, Fischer J, Flandrin G, Berger R, Schaison G, Degos L, Boiron M (1984) Acute promyelocytic leukemia: retrospective study of 119 patients treated with daunorubicin (in French). Nouv Rev Fr Hematol 26:371-378
-
(1984)
Nouv Rev Fr Hematol
, vol.26
, pp. 371-378
-
-
Marty, M.1
Ganem, G.2
Fischer, J.3
Flandrin, G.4
Berger, R.5
Schaison, G.6
Degos, L.7
Boiron, M.8
-
16
-
-
0029131724
-
Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia
-
Head DR, Kopecky KJ, Weick J, Files FC, Ryan D, Foucar K, Montiel Bickers J, Fishleder A, Miller M, et al (1995) Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia. Blood 86:1717-1728
-
(1995)
Blood
, vol.86
, pp. 1717-1728
-
-
Head, D.R.1
Kopecky, K.J.2
Weick, J.3
Files, F.C.4
Ryan, D.5
Foucar, K.6
Montiel Bickers, J.7
Fishleder, A.8
Miller, M.9
-
17
-
-
0036838645
-
Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: Final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up
-
Avvisatti G, Petti MC, Lo-Coco F, et al (2002) Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up. Blood 100:3141-3146
-
(2002)
Blood
, vol.100
, pp. 3141-3146
-
-
Avvisatti, G.1
Petti, M.C.2
Lo-Coco, F.3
-
18
-
-
0021366729
-
Primary therapy of acute promyelocytic leukemia: Results of amsacrine- and daunorubicin-based therapy
-
Arlin Z, Kempin S, Mertelsmann R, Gee T, Higgins C, Jhanwar S, Chaganti RS, Clarkson B (1984) Primary therapy of acute promyelocytic leukemia: results of amsacrine- and daunorubicin-based therapy. Blood 63:211-212
-
(1984)
Blood
, vol.63
, pp. 211-212
-
-
Arlin, Z.1
Kempin, S.2
Mertelsmann, R.3
Gee, T.4
Higgins, C.5
Jhanwar, S.6
Chaganti, R.S.7
Clarkson, B.8
-
20
-
-
0028948122
-
Short-term treatment for adult hypergranular and microgranular acute promyelocytic leukemia
-
Bassan R, Battista R, Viero P, d'Emilio A, Buelli M, Montaldi A, Rambaldi A, Tremul L, Dini E, Barbui T (1995) Short-term treatment for adult hypergranular and microgranular acute promyelocytic leukemia. Leukemia 9:238-243
-
(1995)
Leukemia
, vol.9
, pp. 238-243
-
-
Bassan, R.1
Battista, R.2
Viero, P.3
d'Emilio, A.4
Buelli, M.5
Montaldi, A.6
Rambaldi, A.7
Tremul, L.8
Dini, E.9
Barbui, T.10
-
21
-
-
34548653068
-
-
Reference deleted in proof
-
Reference deleted in proof
-
-
-
-
22
-
-
0021948084
-
Acute promyelocytic leukemia in 57 previously untreated patients
-
Cordonnier C, Vernant JP, Brun B, Heilmann MG, Kuentz M, Bierling P, Farcet JP, Rodet M, Duedari N, Imbert M, et al (1985) Acute promyelocytic leukemia in 57 previously untreated patients. Cancer 55:18-25
-
(1985)
Cancer
, vol.55
, pp. 18-25
-
-
Cordonnier, C.1
Vernant, J.P.2
Brun, B.3
Heilmann, M.G.4
Kuentz, M.5
Bierling, P.6
Farcet, J.P.7
Rodet, M.8
Duedari, N.9
Imbert, M.10
-
23
-
-
0022522965
-
Acute promyelocytic leukemia. MD Anderson Hospital experience
-
Kantarjian HM, Keating MJ, Walters RS, Estey EH, McCredie KB, Smith TL, Dalton WT Jr, Cork A, Trujillo JM, Freireich EJ (1986) Acute promyelocytic leukemia. MD Anderson Hospital experience. Am J Med 80:789-797
-
(1986)
Am J Med
, vol.80
, pp. 789-797
-
-
Kantarjian, H.M.1
Keating, M.J.2
Walters, R.S.3
Estey, E.H.4
McCredie, K.B.5
Smith, T.L.6
Dalton Jr, W.T.7
Cork, A.8
Trujillo, J.M.9
Freireich, E.J.10
-
24
-
-
0025836467
-
Treatment of acute promyelocytic leukemia: A report of 70 cases
-
Fenaux P, Pollet J, Vandebossche L, et al (1991) Treatment of acute promyelocytic leukemia: a report of 70 cases. Leuk Lymphoma 4:249-256
-
(1991)
Leuk Lymphoma
, vol.4
, pp. 249-256
-
-
Fenaux, P.1
Pollet, J.2
Vandebossche, L.3
-
25
-
-
0023752982
-
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
-
Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567-572
-
(1988)
Blood
, vol.72
, pp. 567-572
-
-
Huang, M.E.1
Ye, Y.C.2
Chen, S.R.3
Chai, J.R.4
Lu, J.X.5
Zhoa, L.6
Gu, L.J.7
Wang, Z.Y.8
-
26
-
-
0025201879
-
All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results
-
Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L (1990) All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76:1704-1709
-
(1990)
Blood
, vol.76
, pp. 1704-1709
-
-
Castaigne, S.1
Chomienne, C.2
Daniel, M.T.3
Ballerini, P.4
Berger, R.5
Fenaux, P.6
Degos, L.7
-
27
-
-
0025223760
-
Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acid
-
Degos L, Chomienne C, Daniel MT, Berger R, Dombret H, Fenaux P, Castaigne S (1990) Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acid. Lancet 336:1440-1441
-
(1990)
Lancet
, vol.336
, pp. 1440-1441
-
-
Degos, L.1
Chomienne, C.2
Daniel, M.T.3
Berger, R.4
Dombret, H.5
Fenaux, P.6
Castaigne, S.7
-
28
-
-
0026040363
-
A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients
-
Chen ZX, Xue YQ, Zhang R, Tao RF, Xia XM, Li C, Wang W, Zu WY, Yao XZ, Ling BJ (1991) A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood 78:1413-1419
-
(1991)
Blood
, vol.78
, pp. 1413-1419
-
-
Chen, Z.X.1
Xue, Y.Q.2
Zhang, R.3
Tao, R.F.4
Xia, X.M.5
Li, C.6
Wang, W.7
Zu, W.Y.8
Yao, X.Z.9
Ling, B.J.10
-
29
-
-
0025882306
-
Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)
-
Warrell RP Jr, Frankel SR, Miller WH Jr, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A, et al (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324:1385-1393
-
(1991)
N Engl J Med
, vol.324
, pp. 1385-1393
-
-
Warrell Jr, R.P.1
Frankel, S.R.2
Miller Jr, W.H.3
Scheinberg, D.A.4
Itri, L.M.5
Hittelman, W.N.6
Vyas, R.7
Andreeff, M.8
Tafuri, A.9
Jakubowski, A.10
-
30
-
-
0025241453
-
All-trans retinoic acid in acutepromyelocytic leukemias. II. Invitrostudies: Structure-function relationship
-
Chomienne C, Ballerini P, Balitrand N, Daniel MT, Fenaux P, Castaigne S, Degos L (1990) All-trans retinoic acid in acutepromyelocytic leukemias. II. Invitrostudies: structure-function relationship. Blood 76:1710-1717
-
(1990)
Blood
, vol.76
, pp. 1710-1717
-
-
Chomienne, C.1
Ballerini, P.2
Balitrand, N.3
Daniel, M.T.4
Fenaux, P.5
Castaigne, S.6
Degos, L.7
-
31
-
-
0026665926
-
Proof of differentiative mode of action of all-trans retinoic acid in acute promyelocytic leukemia using X-linked clonal analysis
-
Elliott S, Taylor K, White S, Rodwell R, Marlton P, Meagher D, Wiley J, Taylor D, Wright S, Timms P (1992) Proof of differentiative mode of action of all-trans retinoic acid in acute promyelocytic leukemia using X-linked clonal analysis. Blood 79:1916-1919
-
(1992)
Blood
, vol.79
, pp. 1916-1919
-
-
Elliott, S.1
Taylor, K.2
White, S.3
Rodwell, R.4
Marlton, P.5
Meagher, D.6
Wiley, J.7
Taylor, D.8
Wright, S.9
Timms, P.10
-
32
-
-
0026787010
-
Remission induction of acute promyelocytic leukemia by all-trans-retinoic acid: Molecular evidence of restoration of normal hematopoiesis after differentiation and subsequent extinction of leukemic clone
-
Ohashi H, Ichikawa A, Takagi N, Hotta T, Naoe T, Ohno R, Saito H (1992) Remission induction of acute promyelocytic leukemia by all-trans-retinoic acid: molecular evidence of restoration of normal hematopoiesis after differentiation and subsequent extinction of leukemic clone. Leukemia 6:859-862
-
(1992)
Leukemia
, vol.6
, pp. 859-862
-
-
Ohashi, H.1
Ichikawa, A.2
Takagi, N.3
Hotta, T.4
Naoe, T.5
Ohno, R.6
Saito, H.7
-
33
-
-
0026788363
-
All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: A pilot study on 26 cases
-
Fenaux P, Castaigne S, Dombret H, Archimbaud E, Duarte M, Morel P, Lamy T, Tilly H, Guerci A, Maloisel F, et al (1992) All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases. Blood 80:2176-2181
-
(1992)
Blood
, vol.80
, pp. 2176-2181
-
-
Fenaux, P.1
Castaigne, S.2
Dombret, H.3
Archimbaud, E.4
Duarte, M.5
Morel, P.6
Lamy, T.7
Tilly, H.8
Guerci, A.9
Maloisel, F.10
-
34
-
-
0026647140
-
The "retinoic acid syndrome" in acute promyelocytic leukemia
-
Frankel SR, Eardley A, Lauwers G, Weiss M, Warrell RP Jr (1992) The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann Intern Med 117:292-296
-
(1992)
Ann Intern Med
, vol.117
, pp. 292-296
-
-
Frankel, S.R.1
Eardley, A.2
Lauwers, G.3
Weiss, M.4
Warrell Jr, R.P.5
-
35
-
-
0029911825
-
Treatment of acute promyelocytic leukaemia
-
Fenaux P, Degos L (1996) Treatment of acute promyelocytic leukaemia. Baillieres Clin Haematol 9:107-128
-
(1996)
Baillieres Clin Haematol
, vol.9
, pp. 107-128
-
-
Fenaux, P.1
Degos, L.2
-
36
-
-
0028228247
-
Prolonged follow-up confirms that alltrans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL Group
-
Fenaux P, Wattel E, Archimbaud E, Sanz M, Hecquet B, Fegueux N, Guerci A, Link H, Fey M, Castaigne S, et al (1994) Prolonged follow-up confirms that alltrans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL Group. Blood 84:666-667
-
(1994)
Blood
, vol.84
, pp. 666-667
-
-
Fenaux, P.1
Wattel, E.2
Archimbaud, E.3
Sanz, M.4
Hecquet, B.5
Fegueux, N.6
Guerci, A.7
Link, H.8
Fey, M.9
Castaigne, S.10
-
37
-
-
0027368561
-
Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group
-
Fenaux P, Le Deley MC, Castaigne S, Archimbaud E, Chomienne C, Link H, Guerci A, Duarte M, Daniel MT, Bowen D, et al (1993) Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group. Blood 82:3241-3249
-
(1993)
Blood
, vol.82
, pp. 3241-3249
-
-
Fenaux, P.1
Le Deley, M.C.2
Castaigne, S.3
Archimbaud, E.4
Chomienne, C.5
Link, H.6
Guerci, A.7
Duarte, M.8
Daniel, M.T.9
Bowen, D.10
-
38
-
-
0033890197
-
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group
-
Fenaux P, Chevret S, Guerci A, Fegueux N, Dombret H, Thomas X, Sanz M, Link H, Maloisel F, Gardin C, Bordessoule D, Stoppa AM, Sadoun A, Muus P, Wandt H, Mineur P, Whittaker JA, Fey M, Daniel MT, Castaigne S, Degos L (2000) Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group. Leukemia 14:1371-1377
-
(2000)
Leukemia
, vol.14
, pp. 1371-1377
-
-
Fenaux, P.1
Chevret, S.2
Guerci, A.3
Fegueux, N.4
Dombret, H.5
Thomas, X.6
Sanz, M.7
Link, H.8
Maloisel, F.9
Gardin, C.10
Bordessoule, D.11
Stoppa, A.M.12
Sadoun, A.13
Muus, P.14
Wandt, H.15
Mineur, P.16
Whittaker, J.A.17
Fey, M.18
Daniel, M.T.19
Castaigne, S.20
Degos, L.21
more..
-
39
-
-
0030923479
-
All-transretinoic acid in acute promyelocytic leukemia
-
Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH (1997) All-transretinoic acid in acute promyelocytic leukemia. N Engl J Med 337:1021-1028
-
(1997)
N Engl J Med
, vol.337
, pp. 1021-1028
-
-
Tallman, M.S.1
Andersen, J.W.2
Schiffer, C.A.3
Appelbaum, F.R.4
Feusner, J.H.5
Ogden, A.6
Shepherd, L.7
Willman, C.8
Bloomfield, C.D.9
Rowe, J.M.10
Wiernik, P.H.11
-
40
-
-
0033566639
-
-
Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaud E, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Makhoul PC, Travade P, Solary E, Fegueux N, Bordessoule D, Miguel JS, Link H, Desablens B, Stamatoullas A, Deconinck E, Maloisel F, Castaigne S, Preudhomme C, Degos L (1999) A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood 94:1192-1200
-
Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaud E, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Makhoul PC, Travade P, Solary E, Fegueux N, Bordessoule D, Miguel JS, Link H, Desablens B, Stamatoullas A, Deconinck E, Maloisel F, Castaigne S, Preudhomme C, Degos L (1999) A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood 94:1192-1200
-
-
-
-
41
-
-
0037115195
-
All-trans retinoic acid in acute promyelocytic leukemia: Long-term outcome and prognostic factor analysis from the North American Intergroup protocol
-
Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Woods WG, Ogden A, Weinstein H, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH (2002) All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood 100:4298-4302
-
(2002)
Blood
, vol.100
, pp. 4298-4302
-
-
Tallman, M.S.1
Andersen, J.W.2
Schiffer, C.A.3
Appelbaum, F.R.4
Feusner, J.H.5
Woods, W.G.6
Ogden, A.7
Weinstein, H.8
Shepherd, L.9
Willman, C.10
Bloomfield, C.D.11
Rowe, J.M.12
Wiernik, P.H.13
-
42
-
-
0032957089
-
Outpatient management of acute promyelocytic leukemia after consolidation chemotherapy
-
Girmenia C, Latagliata R, Tosti S, Morano SG, Celesti F, Coppola L, Spadea A, Breccia M, Battistini R, Tafuri A, Cimino G, Mandelli F, Alimena G (1999) Outpatient management of acute promyelocytic leukemia after consolidation chemotherapy. Leukemia 13:514-517
-
(1999)
Leukemia
, vol.13
, pp. 514-517
-
-
Girmenia, C.1
Latagliata, R.2
Tosti, S.3
Morano, S.G.4
Celesti, F.5
Coppola, L.6
Spadea, A.7
Breccia, M.8
Battistini, R.9
Tafuri, A.10
Cimino, G.11
Mandelli, F.12
Alimena, G.13
-
43
-
-
0033564337
-
Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: Result of the Randomized MRC Trial
-
Burnett AK, Grimwade D, Solomon E, Wheatley K, Goldstone AH (1999) Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial. Blood 93:4131-4143
-
(1999)
Blood
, vol.93
, pp. 4131-4143
-
-
Burnett, A.K.1
Grimwade, D.2
Solomon, E.3
Wheatley, K.4
Goldstone, A.H.5
-
44
-
-
0032532009
-
Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group
-
De Botton S, Dombret H, Sanz M, Miguel JS, Caillot D, Zittoun R, Gardembas M, Stamatoulas A, Conde E, Guerci A, Gardin C, Geiser K, Makhoul DC, Reman O, de la Serna J, Lefrere F, Chomienne C, Chastang C, Degos L, Fenaux P (1998) Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood 92:2712-2718
-
(1998)
Blood
, vol.92
, pp. 2712-2718
-
-
De Botton, S.1
Dombret, H.2
Sanz, M.3
Miguel, J.S.4
Caillot, D.5
Zittoun, R.6
Gardembas, M.7
Stamatoulas, A.8
Conde, E.9
Guerci, A.10
Gardin, C.11
Geiser, K.12
Makhoul, D.C.13
Reman, O.14
de la Serna, J.15
Lefrere, F.16
Chomienne, C.17
Chastang, C.18
Degos, L.19
Fenaux, P.20
more..
-
45
-
-
0027133420
-
2) in acute promyelocytic leukemia
-
2) in acute promyelocytic leukemia. Blood 82:3560-3563
-
(1993)
Blood
, vol.82
, pp. 3560-3563
-
-
Castaigne, S.1
Lefebvre, P.2
Chomienne, C.3
Suc, E.4
Rigal-Huguet, F.5
Gardin, C.6
Delmer, A.7
Archimbaud, E.8
Tilly, H.9
Janvier, M.10
-
46
-
-
0027379018
-
Tretinoin toxicity in children with acute promyelocytic leukaemia
-
Mahmoud HH, Hurwitz CA, Roberts WM, Santana VM, Ribeiro RC, Krance RA (1993) Tretinoin toxicity in children with acute promyelocytic leukaemia. Lancet 342:1394-1395
-
(1993)
Lancet
, vol.342
, pp. 1394-1395
-
-
Mahmoud, H.H.1
Hurwitz, C.A.2
Roberts, W.M.3
Santana, V.M.4
Ribeiro, R.C.5
Krance, R.A.6
-
47
-
-
0034663162
-
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: A joint study of the PETHEMA and GIMEMA cooperative groups
-
Sanz MA, Lo-Coco F (2000) Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood 96:1247-1253
-
(2000)
Blood
, vol.96
, pp. 1247-1253
-
-
Sanz, M.A.1
Lo-Coco, F.2
-
48
-
-
0031017173
-
Treatment of newly diagnosed acute promyelocytic leukemiawithout cytarabine
-
Estey E, Thall PF, Pierce S, Kantarjian H, Keating M (1997) Treatment of newly diagnosed acute promyelocytic leukemiawithout cytarabine. J Clin Oncol 15:483-490
-
(1997)
J Clin Oncol
, vol.15
, pp. 483-490
-
-
Estey, E.1
Thall, P.F.2
Pierce, S.3
Kantarjian, H.4
Keating, M.5
-
49
-
-
0026684811
-
Induction of retinoic acid-binding protein in normal and malignant humanmyeloid cells by retinoic acid in acute promyelocytic leukemia patients
-
Cornic M, Delva L, Guidez F, Balitrand N, Degos L, Chomienne C (1992) Induction of retinoic acid-binding protein in normal and malignant humanmyeloid cells by retinoic acid in acute promyelocytic leukemia patients. Cancer Res 52:3329-3334
-
(1992)
Cancer Res
, vol.52
, pp. 3329-3334
-
-
Cornic, M.1
Delva, L.2
Guidez, F.3
Balitrand, N.4
Degos, L.5
Chomienne, C.6
-
50
-
-
0026536835
-
Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: Implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia
-
Muindi J, Frankel SR, Miller WH Jr, Jakubowski A, Scheinberg DA, Young CW, Dmitrovsky E, Warrell RP Jr (1992) Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia. Blood 79:299-303
-
(1992)
Blood
, vol.79
, pp. 299-303
-
-
Muindi, J.1
Frankel, S.R.2
Miller Jr, W.H.3
Jakubowski, A.4
Scheinberg, D.A.5
Young, C.W.6
Dmitrovsky, E.7
Warrell Jr, R.P.8
-
51
-
-
0029054495
-
Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule
-
Adamson PC, Bailey J, Pluda J, Poplack DG, Bauza S, Murphy RF, Yarchoan R, Balis FM (1995) Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule. J Clin Oncol 13:1238-1241
-
(1995)
J Clin Oncol
, vol.13
, pp. 1238-1241
-
-
Adamson, P.C.1
Bailey, J.2
Pluda, J.3
Poplack, D.G.4
Bauza, S.5
Murphy, R.F.6
Yarchoan, R.7
Balis, F.M.8
-
52
-
-
10744220024
-
Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: A multicenter study par the PETHEMA group
-
Sanz A, Martin G, Gonzalez M, et al (2004) Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study par the PETHEMA group. Blood 103:1237-1243
-
(2004)
Blood
, vol.103
, pp. 1237-1243
-
-
Sanz, A.1
Martin, G.2
Gonzalez, M.3
-
53
-
-
0031961755
-
Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
-
Asou N, Adachi K, Tamura J, Kanamaru A, Kageyama S, Hiraoka A, Omoto E, Akiyama H, Tsubaki K, Saito K, Kuriyama K, Oh H, Kitano K, Miyawaki S, Takeyama K, Yamada O, Nishikawa K, Takahashi M, Matsuda S, Ohtake S, Suzushima H, Emi N, Ohno R (1998) Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group. J Clin Oncol 16:78-85
-
(1998)
Japan Adult Leukemia Study Group. J Clin Oncol
, vol.16
, pp. 78-85
-
-
Asou, N.1
Adachi, K.2
Tamura, J.3
Kanamaru, A.4
Kageyama, S.5
Hiraoka, A.6
Omoto, E.7
Akiyama, H.8
Tsubaki, K.9
Saito, K.10
Kuriyama, K.11
Oh, H.12
Kitano, K.13
Miyawaki, S.14
Takeyama, K.15
Yamada, O.16
Nishikawa, K.17
Takahashi, M.18
Matsuda, S.19
Ohtake, S.20
Suzushima, H.21
Emi, N.22
Ohno, R.23
more..
-
54
-
-
0026691334
-
Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia
-
Claxton DF, Reading CL, Nagarajan L, Tsujimoto Y, Andersson BS, Estey E, Cork A, Huh YO, Trujillo J, Deisseroth AB (1992) Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia. Blood 80:582-586
-
(1992)
Blood
, vol.80
, pp. 582-586
-
-
Claxton, D.F.1
Reading, C.L.2
Nagarajan, L.3
Tsujimoto, Y.4
Andersson, B.S.5
Estey, E.6
Cork, A.7
Huh, Y.O.8
Trujillo, J.9
Deisseroth, A.B.10
-
55
-
-
0028318936
-
The immunophenotype of acute promyelocytic leukemia (APL): An ECOG study
-
Paietta E, Andersen J, Gallagher R, Bennett J, Yunis J, Cassileth P, Rowe J, Wiernik PH (1994) The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study. Leukemia 8:1108-1112
-
(1994)
Leukemia
, vol.8
, pp. 1108-1112
-
-
Paietta, E.1
Andersen, J.2
Gallagher, R.3
Bennett, J.4
Yunis, J.5
Cassileth, P.6
Rowe, J.7
Wiernik, P.H.8
-
56
-
-
0344336086
-
Immunophenotype of adult and childhood acute promyelocytic leukaemia: Correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases
-
Guglielmi C, Martelli MP, Diverio D, Fenu S, Vegna ML, Cantu-Rajnoldi A, Biondi A, Cocito MG, Del Vecchio L, Tabilio A, Avvisati G, Basso G, Lo Coco F (1998) Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases. Br J Haematol 102:1035-1041
-
(1998)
Br J Haematol
, vol.102
, pp. 1035-1041
-
-
Guglielmi, C.1
Martelli, M.P.2
Diverio, D.3
Fenu, S.4
Vegna, M.L.5
Cantu-Rajnoldi, A.6
Biondi, A.7
Cocito, M.G.8
Del Vecchio, L.9
Tabilio, A.10
Avvisati, G.11
Basso, G.12
Lo Coco, F.13
-
57
-
-
0032923932
-
CD56 expression in acute promyelocytic leukemia: A possible indicator of poor treatment outcome?
-
Murray CK, Estey E, Paietta E, Howard RS, Edenfield WJ, Pierce S, Mann KP, Bolan C, Byrd JC (1999) CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome? J Clin Oncol 17:293-297
-
(1999)
J Clin Oncol
, vol.17
, pp. 293-297
-
-
Murray, C.K.1
Estey, E.2
Paietta, E.3
Howard, R.S.4
Edenfield, W.J.5
Pierce, S.6
Mann, K.P.7
Bolan, C.8
Byrd, J.C.9
-
58
-
-
0035525766
-
In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: A novel indicator of poor patient outcome
-
Cassinat B, Chevret S, Zassadowski F, Balitrand N, Guillemot I, Menot ML, Degos L, et al (2001) In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: a novel indicator of poor patient outcome. Blood 98:2862-2864
-
(2001)
Blood
, vol.98
, pp. 2862-2864
-
-
Cassinat, B.1
Chevret, S.2
Zassadowski, F.3
Balitrand, N.4
Guillemot, I.5
Menot, M.L.6
Degos, L.7
-
59
-
-
0035525767
-
Prognostic significance of minimal residual disease detection and PML/RAR- isoformtype: Long-term follow-up in acute promyelocytic leukemia
-
Jurcic JG, Nimer SD, Scheinberg DA, DeBlasio T, Warrell RP Jr, Miller WH Jr (2001) Prognostic significance of minimal residual disease detection and PML/RAR- isoformtype: long-term follow-up in acute promyelocytic leukemia. Blood 98:2651-2656
-
(2001)
Blood
, vol.98
, pp. 2651-2656
-
-
Jurcic, J.G.1
Nimer, S.D.2
Scheinberg, D.A.3
DeBlasio, T.4
Warrell Jr, R.P.5
Miller Jr, W.H.6
-
60
-
-
0032147033
-
Early detection of relapse by prospective reverse transcriptase- polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Multicenter "AIDA" Trial
-
Diverio D, Rossi V, Avvisati G, De Santis S, Pistilli A, Pane F, Saglio G, Martinelli G, Petti MC, Santoro A, Pelicci PG, Mandelli F, Biondi A, Lo Coco F (1998) Early detection of relapse by prospective reverse transcriptase- polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Multicenter "AIDA" Trial. Blood 92:784-789
-
(1998)
Blood
, vol.92
, pp. 784-789
-
-
Diverio, D.1
Rossi, V.2
Avvisati, G.3
De Santis, S.4
Pistilli, A.5
Pane, F.6
Saglio, G.7
Martinelli, G.8
Petti, M.C.9
Santoro, A.10
Pelicci, P.G.11
Mandelli, F.12
Biondi, A.13
Lo Coco, F.14
-
61
-
-
0033975927
-
Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RTPCR
-
Cassinat B, Zassadowski F, Balitrand N, Barbey C, Rain JD, Fenaux P, Degos L, Vidaud M, Chomienne C (2000) Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RTPCR. Leukemia 14:324
-
(2000)
Leukemia
, vol.14
, pp. 324
-
-
Cassinat, B.1
Zassadowski, F.2
Balitrand, N.3
Barbey, C.4
Rain, J.D.5
Fenaux, P.6
Degos, L.7
Vidaud, M.8
Chomienne, C.9
-
62
-
-
0035158509
-
Pulsed ATRA as single therapy restores long-term remission PML-RARalpha-positive acute promyelocytic leukemia patient real time quantification of minimal residual disease. A pilot study
-
Visani G, Buonamici S, Malagola M, Isidori A, Piccaluga PP, Martin G, Ottaviani E, Grafone T, Baccarani M, Tura S (2000) Pulsed ATRA as single therapy restores long-term remission PML-RARalpha-positive acute promyelocytic leukemia patient real time quantification of minimal residual disease. A pilot study. Leukemia 15:1696-1700
-
(2000)
Leukemia
, vol.15
, pp. 1696-1700
-
-
Visani, G.1
Buonamici, S.2
Malagola, M.3
Isidori, A.4
Piccaluga, P.P.5
Martin, G.6
Ottaviani, E.7
Grafone, T.8
Baccarani, M.9
Tura, S.10
-
63
-
-
0038446666
-
Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: Assessment of prognostic significance in adult patients from intergroup protocol 0129
-
Gallagher RE, Yeap BY, Bi W, et al (2003) Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129. Blood 101:2521-2528
-
(2003)
Blood
, vol.101
, pp. 2521-2528
-
-
Gallagher, R.E.1
Yeap, B.Y.2
Bi, W.3
-
64
-
-
17344370602
-
Preliminary experience in external quality control of RT-PCR PML-RAR alpha detection in promyelocytic leukemia
-
Bolufer P, Barragan E, Sanz MA, Martin G, Bornstein R, Colomer D, Delgado MD, Gonzalez M, Marugan I, Roman J, Gomez MT, Anguita E, Diverio D, Chomienne C, Briz M (1998) Preliminary experience in external quality control of RT-PCR PML-RAR alpha detection in promyelocytic leukemia. Leukemia 12:2024-2028
-
(1998)
Leukemia
, vol.12
, pp. 2024-2028
-
-
Bolufer, P.1
Barragan, E.2
Sanz, M.A.3
Martin, G.4
Bornstein, R.5
Colomer, D.6
Delgado, M.D.7
Gonzalez, M.8
Marugan, I.9
Roman, J.10
Gomez, M.T.11
Anguita, E.12
Diverio, D.13
Chomienne, C.14
Briz, M.15
-
65
-
-
0032946404
-
Extramedullary disease in acute promyelocytic leukemia
-
Evans GD, Grimwade DJ (1999) Extramedullary disease in acute promyelocytic leukemia. Leuk Lymphoma 33:219-229
-
(1999)
Leuk Lymphoma
, vol.33
, pp. 219-229
-
-
Evans, G.D.1
Grimwade, D.J.2
-
66
-
-
33644976445
-
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
-
de Botton S, Sanz M, Chevret S, et al (2006) Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia 20:35-41
-
(2006)
Leukemia
, vol.20
, pp. 35-41
-
-
de Botton, S.1
Sanz, M.2
Chevret, S.3
-
67
-
-
34548621538
-
-
Lo-Coco F, Vignetti M, Avvisatti G, et al (2004) Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation: results of the AIDA-2000 trial of the Italian GIMEMA group. Blood 104 Suppl 1 Abstr 392
-
Lo-Coco F, Vignetti M, Avvisatti G, et al (2004) Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation: results of the AIDA-2000 trial of the Italian GIMEMA group. Blood 104 Suppl 1 Abstr 392
-
-
-
-
68
-
-
0033858433
-
Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: Effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group
-
Lengfelder E, Reichert A, Schoch C, et al (2000) Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group. Leukemia 14:1362-1370
-
(2000)
Leukemia
, vol.14
, pp. 1362-1370
-
-
Lengfelder, E.1
Reichert, A.2
Schoch, C.3
-
69
-
-
0028557482
-
Treatment of acute promyelocytic leukemia with all-trans retinoic acid: An update of the New York experience
-
Warrell RP Jr, Maslak P, Eardley A, Heller G, Miller WH Jr, Frankel SR (1994) Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience. Leukemia 8:929-933
-
(1994)
Leukemia
, vol.8
, pp. 929-933
-
-
Warrell Jr, R.P.1
Maslak, P.2
Eardley, A.3
Heller, G.4
Miller Jr, W.H.5
Frankel, S.R.6
-
70
-
-
0027517243
-
Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: Study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells
-
Delva L, Cornic M, Balitrand N, Guidez F, Miclea JM, Delmer A, Teillet F, Fenaux P, Castaigne S, Degos L, et al (1993) Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells. Blood 82:2175-2181
-
(1993)
Blood
, vol.82
, pp. 2175-2181
-
-
Delva, L.1
Cornic, M.2
Balitrand, N.3
Guidez, F.4
Miclea, J.M.5
Delmer, A.6
Teillet, F.7
Fenaux, P.8
Castaigne, S.9
Degos, L.10
-
71
-
-
0034046084
-
-
Thomas X, Dombret H, Cordonnier C, Pigneux A, Gardin C, Guerci A, Vekhoff A, Sadoun A, Stamatoullas A, Fegueux N, Maloisel F, Cahn JY, Reman O, Gratecos N, Berthou C, Huguet F, Kotoucek P, Travade P, Buzyn A, de Revel T, Vilque JP, Naccache P, Chomienne C, Degos L, Fenaux P (2000) Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia. Leukemia 14:1006-1013
-
Thomas X, Dombret H, Cordonnier C, Pigneux A, Gardin C, Guerci A, Vekhoff A, Sadoun A, Stamatoullas A, Fegueux N, Maloisel F, Cahn JY, Reman O, Gratecos N, Berthou C, Huguet F, Kotoucek P, Travade P, Buzyn A, de Revel T, Vilque JP, Naccache P, Chomienne C, Degos L, Fenaux P (2000) Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia. Leukemia 14:1006-1013
-
-
-
-
72
-
-
16644373167
-
Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: A retrospective analysis of the European acute promyelocytic leukemia group
-
de Botton S, Fawaz A, Chevret S, et al (2005) Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group. J Clin Oncol 23:120-126
-
(2005)
J Clin Oncol
, vol.23
, pp. 120-126
-
-
de Botton, S.1
Fawaz, A.2
Chevret, S.3
-
73
-
-
0032529284
-
Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy
-
Ding W, Li YP, Nobile LM, Grills G, Carrera I, Paietta E, Tallman MS, Wiernik PH, Gallagher RE (1998) Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy. Blood 92:1172-1183
-
(1998)
Blood
, vol.92
, pp. 1172-1183
-
-
Ding, W.1
Li, Y.P.2
Nobile, L.M.3
Grills, G.4
Carrera, I.5
Paietta, E.6
Tallman, M.S.7
Wiernik, P.H.8
Gallagher, R.E.9
-
74
-
-
0035169587
-
Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid
-
Douer D, Estey E, Santillana S, Bennett JM, Lopez-Bernstein G, et al (2001) Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid. Blood 97:73-80
-
(2001)
Blood
, vol.97
, pp. 73-80
-
-
Douer, D.1
Estey, E.2
Santillana, S.3
Bennett, J.M.4
Lopez-Bernstein, G.5
-
75
-
-
0028109056
-
Liposome encapsulation circumvents the hepatic clearance mechanisms of all-trans-retinoic acid
-
Mehta K, Sadeghi T, McQueen T, Lopez-Berestein G (1994) Liposome encapsulation circumvents the hepatic clearance mechanisms of all-trans-retinoic acid. Leuk Res 18:587-596
-
(1994)
Leuk Res
, vol.18
, pp. 587-596
-
-
Mehta, K.1
Sadeghi, T.2
McQueen, T.3
Lopez-Berestein, G.4
-
76
-
-
0031656210
-
Clinical study of 9-cis retinoic acid (LGD1057) in acute promyelocytic leukemia
-
Soignet SL, Benedetti F, Fleischauer A, Parker BA, Truglia JA, Ra Crisp M, Warrell RP Jr (1998) Clinical study of 9-cis retinoic acid (LGD1057) in acute promyelocytic leukemia. Leukemia 12:1518-1521
-
(1998)
Leukemia
, vol.12
, pp. 1518-1521
-
-
Soignet, S.L.1
Benedetti, F.2
Fleischauer, A.3
Parker, B.A.4
Truglia, J.A.5
Ra Crisp, M.6
Warrell Jr, R.P.7
-
77
-
-
0029050432
-
9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia
-
Miller WH, Jakubowski A, Tong WP, Miller VA, Rigas JR, Benedetti F, Gill GM, Truglia JA, Ulm E, Shirley M (1995) 9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia. Blood 85:3021
-
(1995)
Blood
, vol.85
, pp. 3021
-
-
Miller, W.H.1
Jakubowski, A.2
Tong, W.P.3
Miller, V.A.4
Rigas, J.R.5
Benedetti, F.6
Gill, G.M.7
Truglia, J.A.8
Ulm, E.9
Shirley, M.10
-
78
-
-
0030738326
-
Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid
-
Tobita T, Takeshita A, Kitamura K, Ohnishi K, Yanagi M, Hiraoka A, Karasuno T, Takeuchi M, Miyawaki S, Ueda R, Naoe T, Ohno R (1997) Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid. Blood 90:967-973
-
(1997)
Blood
, vol.90
, pp. 967-973
-
-
Tobita, T.1
Takeshita, A.2
Kitamura, K.3
Ohnishi, K.4
Yanagi, M.5
Hiraoka, A.6
Karasuno, T.7
Takeuchi, M.8
Miyawaki, S.9
Ueda, R.10
Naoe, T.11
Ohno, R.12
-
79
-
-
3643104150
-
Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase
-
Warrell RP Jr, He LZ, Richon V, Calleja E, Pandolfi PP (1998) Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J Natl Cancer Inst 90:1621-1625
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 1621-1625
-
-
Warrell Jr, R.P.1
He, L.Z.2
Richon, V.3
Calleja, E.4
Pandolfi, P.P.5
-
80
-
-
0032879920
-
Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: A new approach to anti-leukemia therapy
-
Kosugi H, Towatari M, Hatano S, Kitamura K, Kiyoi H, Kinoshita T, Tanimoto M, Murate T, Kawashima K, Saito H, Naoe T (1999) Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy. Leukemia 13:1316-1324
-
(1999)
Leukemia
, vol.13
, pp. 1316-1324
-
-
Kosugi, H.1
Towatari, M.2
Hatano, S.3
Kitamura, K.4
Kiyoi, H.5
Kinoshita, T.6
Tanimoto, M.7
Murate, T.8
Kawashima, K.9
Saito, H.10
Naoe, T.11
-
81
-
-
0033982749
-
Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia
-
Jurcic JG, DeBlasio T, Dumont L, Yao TJ, Scheinberg DA (2000) Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia. Clin Cancer Res 6:372-380
-
(2000)
Clin Cancer Res
, vol.6
, pp. 372-380
-
-
Jurcic, J.G.1
DeBlasio, T.2
Dumont, L.3
Yao, T.J.4
Scheinberg, D.A.5
-
82
-
-
0034773130
-
Prolonged molecular remission in advanced acute promyelocytic leukaemia after treatment with gemtuzumab ozogamicin (Mylotarg CMA-676)
-
Petti MC, Pinazzi MB, Diverio D, Romano A, Petrucci MT, De Santis S, Meloni G, Tafuri A, Mandelli F, LoCoco F (2001) Prolonged molecular remission in advanced acute promyelocytic leukaemia after treatment with gemtuzumab ozogamicin (Mylotarg CMA-676). Br J Haematol 115:63-65
-
(2001)
Br J Haematol
, vol.115
, pp. 63-65
-
-
Petti, M.C.1
Pinazzi, M.B.2
Diverio, D.3
Romano, A.4
Petrucci, M.T.5
De Santis, S.6
Meloni, G.7
Tafuri, A.8
Mandelli, F.9
LoCoco, F.10
-
83
-
-
4243299380
-
Study on anti-leukemic effect of tanshinone IIA in vitro and in vivo to acute promyelocytic leukemia
-
Yang Y, Liu T, Liang Y, Qin P, Yuan S (1994) Study on anti-leukemic effect of tanshinone IIA in vitro and in vivo to acute promyelocytic leukemia. Blood 94 Suppl 1
-
(1994)
Blood
, vol.94
, Issue.SUPPL. 1
-
-
Yang, Y.1
Liu, T.2
Liang, Y.3
Qin, P.4
Yuan, S.5
-
84
-
-
0030610687
-
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL). II. Clinical efficacy and pharmacokinetics in relapsed patients
-
Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM, Qiu QY, Zhu J, Tang W, Sun GL, Yang KQ, Chen Y, Zhou L, Fang ZW, Wang YT, Ma J, Zhang P, Zhang TD, Chen SJ, Chen Z, Wang ZY (1997) Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL). II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 89:3354-3360
-
(1997)
Blood
, vol.89
, pp. 3354-3360
-
-
Shen, Z.X.1
Chen, G.Q.2
Ni, J.H.3
Li, X.S.4
Xiong, S.M.5
Qiu, Q.Y.6
Zhu, J.7
Tang, W.8
Sun, G.L.9
Yang, K.Q.10
Chen, Y.11
Zhou, L.12
Fang, Z.W.13
Wang, Y.T.14
Ma, J.15
Zhang, P.16
Zhang, T.D.17
Chen, S.J.18
Chen, Z.19
Wang, Z.Y.20
more..
-
85
-
-
0032487923
-
Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide
-
Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, Corso D, DeBlasio A, Gabrilove J, Scheinberg DA, Pandolfi PP, Warrell RP Jr (1998) Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 339:1341-1348
-
(1998)
N Engl J Med
, vol.339
, pp. 1341-1348
-
-
Soignet, S.L.1
Maslak, P.2
Wang, Z.G.3
Jhanwar, S.4
Calleja, E.5
Dardashti, L.J.6
Corso, D.7
DeBlasio, A.8
Gabrilove, J.9
Scheinberg, D.A.10
Pandolfi, P.P.11
Warrell Jr, R.P.12
-
86
-
-
0033570955
-
Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: Remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients
-
Niu C, Yan H, Yu T, Sun HP, Liu JX, Li XS, Wu W, Zhang FQ, Chen Y, Zhou L, Li JM, Zeng XY, Yang RR, Yuan MM, Ren MY, Gu FY, Cao Q, Gu BW, Su XY, Chen GQ, Xiong SM, Zhang T, Waxman S, Wang ZY, Chen SJ, et al (1999) Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients. Blood 94:3315-3324
-
(1999)
Blood
, vol.94
, pp. 3315-3324
-
-
Niu, C.1
Yan, H.2
Yu, T.3
Sun, H.P.4
Liu, J.X.5
Li, X.S.6
Wu, W.7
Zhang, F.Q.8
Chen, Y.9
Zhou, L.10
Li, J.M.11
Zeng, X.Y.12
Yang, R.R.13
Yuan, M.M.14
Ren, M.Y.15
Gu, F.Y.16
Cao, Q.17
Gu, B.W.18
Su, X.Y.19
Chen, G.Q.20
Xiong, S.M.21
Zhang, T.22
Waxman, S.23
Wang, Z.Y.24
Chen, S.J.25
more..
-
87
-
-
0035884639
-
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia
-
Soignet SL, Frankel SR, Douer D, Tallman MS, Kantarjian H, Calleja E, Stone RM, Kalaycio M, Scheinberg DA, Steinherz P, Sievers EL, Coutre S, Dahlberg S, Ellison R, Warrell RP Jr (2001) United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol 19:3852-3860
-
(2001)
J Clin Oncol
, vol.19
, pp. 3852-3860
-
-
Soignet, S.L.1
Frankel, S.R.2
Douer, D.3
Tallman, M.S.4
Kantarjian, H.5
Calleja, E.6
Stone, R.M.7
Kalaycio, M.8
Scheinberg, D.A.9
Steinherz, P.10
Sievers, E.L.11
Coutre, S.12
Dahlberg, S.13
Ellison, R.14
Warrell Jr, R.P.15
-
88
-
-
0036090647
-
Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: A bridge to transplantation
-
Leoni F, Gianfaldoni G, Annunziata M, Fanci R, Ciolli S, Nozzoli C, Ferrara F (2002) Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: a bridge to transplantation. Haematologica 87:485-489
-
(2002)
Haematologica
, vol.87
, pp. 485-489
-
-
Leoni, F.1
Gianfaldoni, G.2
Annunziata, M.3
Fanci, R.4
Ciolli, S.5
Nozzoli, C.6
Ferrara, F.7
-
89
-
-
0034610263
-
Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia
-
Ohnishi K, Yoshida H, Shigeno K, Nakamura S, Fujisawa S, Naito K, Shinjo K, Fujita Y, Matsui H, Takeshita A, Sugiyama S, Satoh H, Terada H, Ohno R (2000) Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Ann Intern Med 133:881-885
-
(2000)
Ann Intern Med
, vol.133
, pp. 881-885
-
-
Ohnishi, K.1
Yoshida, H.2
Shigeno, K.3
Nakamura, S.4
Fujisawa, S.5
Naito, K.6
Shinjo, K.7
Fujita, Y.8
Matsui, H.9
Takeshita, A.10
Sugiyama, S.11
Satoh, H.12
Terada, H.13
Ohno, R.14
-
90
-
-
0035880237
-
Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide
-
Westervelt P, Brown RA, Adkins DR, Khoury H, Curtin P, Hurd D, Luger SM, Ma MK, Ley TJ, DiPersio JF (2001) Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide. Blood 98:266-271
-
(2001)
Blood
, vol.98
, pp. 266-271
-
-
Westervelt, P.1
Brown, R.A.2
Adkins, D.R.3
Khoury, H.4
Curtin, P.5
Hurd, D.6
Luger, S.M.7
Ma, M.K.8
Ley, T.J.9
DiPersio, J.F.10
-
91
-
-
0035095714
-
Arsenic trioxide-and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: Clinicopathological and molecular features of a pilot study
-
Kwong YL, Au WY, Chim CS, Pang A, Suen C, Liang R (2001) Arsenic trioxide-and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study. Am J Hematol 66:274-279
-
(2001)
Am J Hematol
, vol.66
, pp. 274-279
-
-
Kwong, Y.L.1
Au, W.Y.2
Chim, C.S.3
Pang, A.4
Suen, C.5
Liang, R.6
-
92
-
-
0035007005
-
Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: A comparison with conventional dosage
-
Shen Y, Shen ZX, Yan H, Chen J, Zeng XY, Li JM, Li XS, Wu W, Xiong SM, Zhao WL, Tang W, Wu F, Liu YF, Niu C, Wang ZY, Chen SJ, Chen Z (2001) Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage. Leukemia 15:735-741
-
(2001)
Leukemia
, vol.15
, pp. 735-741
-
-
Shen, Y.1
Shen, Z.X.2
Yan, H.3
Chen, J.4
Zeng, X.Y.5
Li, J.M.6
Li, X.S.7
Wu, W.8
Xiong, S.M.9
Zhao, W.L.10
Tang, W.11
Wu, F.12
Liu, Y.F.13
Niu, C.14
Wang, Z.Y.15
Chen, S.J.16
Chen, Z.17
-
93
-
-
0034554742
-
Hyperleukocytosis during induction therapy with arsenic trioxide for relapsed acute promyelocytic leukemia associated with central nervous system infarction
-
Roberts TF, Sprague K, Schenkein D, Miller KB, Relias V (2000) Hyperleukocytosis during induction therapy with arsenic trioxide for relapsed acute promyelocytic leukemia associated with central nervous system infarction. Blood 96:4000-4001
-
(2000)
Blood
, vol.96
, pp. 4000-4001
-
-
Roberts, T.F.1
Sprague, K.2
Schenkein, D.3
Miller, K.B.4
Relias, V.5
-
94
-
-
0033916673
-
Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide
-
Camacho LH, Soignet SL, Chanel S, Ho R, Heller G, Scheinberg DA, Ellison R, Warrell RP Jr (2000) Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide. J Clin Oncol 18:2620-2625
-
(2000)
J Clin Oncol
, vol.18
, pp. 2620-2625
-
-
Camacho, L.H.1
Soignet, S.L.2
Chanel, S.3
Ho, R.4
Heller, G.5
Scheinberg, D.A.6
Ellison, R.7
Warrell Jr, R.P.8
-
95
-
-
0034050085
-
Retinoic acid syndrome induced by arsenic trioxide in treating recurrent all-trans retinoic acid resistant acute promyelocytic leukemia
-
Che-Pin L, Huang MJ, Chang IY, Lin WY, Sheu YT (2000) Retinoic acid syndrome induced by arsenic trioxide in treating recurrent all-trans retinoic acid resistant acute promyelocytic leukemia. Leuk Lymphoma 38:195-198
-
(2000)
Leuk Lymphoma
, vol.38
, pp. 195-198
-
-
Che-Pin, L.1
Huang, M.J.2
Chang, I.Y.3
Lin, W.Y.4
Sheu, Y.T.5
-
96
-
-
0035283137
-
Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide
-
Unnikrishnan D, Dutcher JP, Varshneya N, Lucariello R, Api M, Garl S, Wiernik PH, Chiaramida S (2001) Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide. Blood 97:1514-1516
-
(2001)
Blood
, vol.97
, pp. 1514-1516
-
-
Unnikrishnan, D.1
Dutcher, J.P.2
Varshneya, N.3
Lucariello, R.4
Api, M.5
Garl, S.6
Wiernik, P.H.7
Chiaramida, S.8
-
97
-
-
0036565879
-
Severe neurotoxicity following arsenic therapy for acute promyelocytic leukemia: Potentiation by thiamine deficiency
-
Yip SF, Yeung YM, Tsui EY (2002) Severe neurotoxicity following arsenic therapy for acute promyelocytic leukemia: potentiation by thiamine deficiency. Blood 99:3481-3482
-
(2002)
Blood
, vol.99
, pp. 3481-3482
-
-
Yip, S.F.1
Yeung, Y.M.2
Tsui, E.Y.3
-
98
-
-
0036566529
-
Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: A pilot report
-
Lu DP, Qiu JY, Jiang B, Wang Q, Liu KY, Liu YR, Chen SS (2002) Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report. Blood 99:3136-3143
-
(2002)
Blood
, vol.99
, pp. 3136-3143
-
-
Lu, D.P.1
Qiu, J.Y.2
Jiang, B.3
Wang, Q.4
Liu, K.Y.5
Liu, Y.R.6
Chen, S.S.7
-
99
-
-
0035161286
-
Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo
-
Jing Y, Wang L, Xia L, Chen GQ, Chen Z, Miller WH, Waxman S (2001) Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo. Blood 97:264-269
-
(2001)
Blood
, vol.97
, pp. 264-269
-
-
Jing, Y.1
Wang, L.2
Xia, L.3
Chen, G.Q.4
Chen, Z.5
Miller, W.H.6
Waxman, S.7
-
100
-
-
0036223312
-
Combined arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia recurring from previous relapses successfully treated using arsenic trioxide
-
Au WY, Chim CS, Lie AK, Liang R, Kwong YL (2002) Combined arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia recurring from previous relapses successfully treated using arsenic trioxide. Br J Haematol 117:130-132
-
(2002)
Br J Haematol
, vol.117
, pp. 130-132
-
-
Au, W.Y.1
Chim, C.S.2
Lie, A.K.3
Liang, R.4
Kwong, Y.L.5
-
101
-
-
0032753459
-
Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia
-
Marasca R, Zucchini P, Galimberti S, Leonardi G, Vaccari P, Donelli A, Luppi M, Petrini M, Torelli G (1999) Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia. Haematologica 84:963-968
-
(1999)
Haematologica
, vol.84
, pp. 963-968
-
-
Marasca, R.1
Zucchini, P.2
Galimberti, S.3
Leonardi, G.4
Vaccari, P.5
Donelli, A.6
Luppi, M.7
Petrini, M.8
Torelli, G.9
-
102
-
-
0032170898
-
Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner
-
Wang ZG, Rivi R, Delva L, Konig A, Scheinberg DA, Gambacorti-Passerini C, Gabrilove JL, Warrell RP Jr, Pandolfi PP (1998) Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner. Blood 92:1497-1504
-
(1998)
Blood
, vol.92
, pp. 1497-1504
-
-
Wang, Z.G.1
Rivi, R.2
Delva, L.3
Konig, A.4
Scheinberg, D.A.5
Gambacorti-Passerini, C.6
Gabrilove, J.L.7
Warrell Jr, R.P.8
Pandolfi, P.P.9
-
103
-
-
0033568238
-
Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway
-
Jing Y, Dai J, Chalmers-Redman RM, Tatton WG, Waxman S (1999) Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 94:2102-2111
-
(1999)
Blood
, vol.94
, pp. 2102-2111
-
-
Jing, Y.1
Dai, J.2
Chalmers-Redman, R.M.3
Tatton, W.G.4
Waxman, S.5
-
105
-
-
0034786069
-
Arsenic trioxide is a potent inhibitor of the interaction of SMRT corepressor with its transcription factor partners, including the PML-retinoic acid receptor alpha oncoprotein found in human acute promyelocytic leukemia
-
Hong SH, Yang Z, Privalsky ML (2001) Arsenic trioxide is a potent inhibitor of the interaction of SMRT corepressor with its transcription factor partners, including the PML-retinoic acid receptor alpha oncoprotein found in human acute promyelocytic leukemia. Mol Cell Biol 21:7172-7182
-
(2001)
Mol Cell Biol
, vol.21
, pp. 7172-7182
-
-
Hong, S.H.1
Yang, Z.2
Privalsky, M.L.3
-
106
-
-
0034663032
-
Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis
-
Roboz GJ, Dias S, Lam G, Lane WJ, Soignet SL, Warrell RP Jr, Rafii S (2000) Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis. Blood 96:1525-1530
-
(2000)
Blood
, vol.96
, pp. 1525-1530
-
-
Roboz, G.J.1
Dias, S.2
Lam, G.3
Lane, W.J.4
Soignet, S.L.5
Warrell Jr, R.P.6
Rafii, S.7
-
107
-
-
0030610686
-
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL). I. As2O3 exerts dose-dependent dual effects on APL cells
-
Chen GQ, Shi XG, Tang W, Xiong SM, Zhu J, Cai X, Han ZG, Ni JH, Shi GY, Jia PM, Liu MM, He KL, Niu C, Ma J, Zhang P, Zhang TD, Paul P, Naoe T, Kitamura K, Miller W, Waxman S, Wang ZY, de The H, Chen SJ, Chen Z (1997) Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL). I. As2O3 exerts dose-dependent dual effects on APL cells. Blood 89:3345-3353
-
(1997)
Blood
, vol.89
, pp. 3345-3353
-
-
Chen, G.Q.1
Shi, X.G.2
Tang, W.3
Xiong, S.M.4
Zhu, J.5
Cai, X.6
Han, Z.G.7
Ni, J.H.8
Shi, G.Y.9
Jia, P.M.10
Liu, M.M.11
He, K.L.12
Niu, C.13
Ma, J.14
Zhang, P.15
Zhang, T.D.16
Paul, P.17
Naoe, T.18
Kitamura, K.19
Miller, W.20
Waxman, S.21
Wang, Z.Y.22
de The, H.23
Chen, S.J.24
Chen, Z.25
more..
-
108
-
-
0033975849
-
Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome
-
Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Rowe JM, Francois C, Larson RS, Wiernik PH (2000) Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood 95:90-95
-
(2000)
Blood
, vol.95
, pp. 90-95
-
-
Tallman, M.S.1
Andersen, J.W.2
Schiffer, C.A.3
Appelbaum, F.R.4
Feusner, J.H.5
Ogden, A.6
Shepherd, L.7
Rowe, J.M.8
Francois, C.9
Larson, R.S.10
Wiernik, P.H.11
-
109
-
-
0028960267
-
All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia
-
Kanamaru A, Takemoto Y, Tanimoto M, Murakami H, Asou N, Kobayashi T, Kuriyama K, Ohmoto E, Sakamaki H, Tsubaki K, et al (1995) All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group. Blood 85:1202-1206
-
(1995)
Japan Adult Leukemia Study Group. Blood
, vol.85
, pp. 1202-1206
-
-
Kanamaru, A.1
Takemoto, Y.2
Tanimoto, M.3
Murakami, H.4
Asou, N.5
Kobayashi, T.6
Kuriyama, K.7
Ohmoto, E.8
Sakamaki, H.9
Tsubaki, K.10
-
110
-
-
0027937940
-
Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: Impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid
-
Vahdat L, Maslak P, Miller WH Jr, Eardley A, Heller G, Scheinberg DA, Warrell RP Jr (1994) Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood 84:3843-3849
-
(1994)
Blood
, vol.84
, pp. 3843-3849
-
-
Vahdat, L.1
Maslak, P.2
Miller Jr, W.H.3
Eardley, A.4
Heller, G.5
Scheinberg, D.A.6
Warrell Jr, R.P.7
-
111
-
-
0032870982
-
Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia - the occurrence of retinoic acid syndrome is a risk factor
-
Ko BS, Tang JL, Chen YC, Yao M, Wang CH, Shen MC, Tien HF (1999) Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia - the occurrence of retinoic acid syndrome is a risk factor. Leukemia 13:1406-1408
-
(1999)
Leukemia
, vol.13
, pp. 1406-1408
-
-
Ko, B.S.1
Tang, J.L.2
Chen, Y.C.3
Yao, M.4
Wang, C.H.5
Shen, M.C.6
Tien, H.F.7
-
112
-
-
0028171394
-
Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia
-
Dubois C, Schlageter MH, de Gentile A, Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean Y, Degos L, et al (1994) Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia. Leukemia 8:1750-1757
-
(1994)
Leukemia
, vol.8
, pp. 1750-1757
-
-
Dubois, C.1
Schlageter, M.H.2
de Gentile, A.3
Balitrand, N.4
Toubert, M.E.5
Krawice, I.6
Fenaux, P.7
Castaigne, S.8
Najean, Y.9
Degos, L.10
-
113
-
-
0028339174
-
-
Dubois C, Schlageter MH, de Gentile A, Guidez F, Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean Y, et al (1994) Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells. Blood 83:3264-3270
-
Dubois C, Schlageter MH, de Gentile A, Guidez F, Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean Y, et al (1994) Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells. Blood 83:3264-3270
-
-
-
-
114
-
-
0030847751
-
Retinoic acid induces aggregation of the acute promyelocytic leukemia cell line NB-4 by utilization of LFA-1 and ICAM-2
-
Larson RS, Brown DC, Sklar LA (1997) Retinoic acid induces aggregation of the acute promyelocytic leukemia cell line NB-4 by utilization of LFA-1 and ICAM-2. Blood 90:2747-2756
-
(1997)
Blood
, vol.90
, pp. 2747-2756
-
-
Larson, R.S.1
Brown, D.C.2
Sklar, L.A.3
-
115
-
-
0028027147
-
Pre-treatment with all-trans retinoic acid accelerates polymorphonuclear recovery after chemotherapy in patients with acute promyelocytic leukemia
-
Visani G, Tosi P, Cenacchi A, Manfroi S, Gamberi B, Ottaviani E, Tura S (1994) Pre-treatment with all-trans retinoic acid accelerates polymorphonuclear recovery after chemotherapy in patients with acute promyelocytic leukemia. Leuk Lymphoma 15:143-147
-
(1994)
Leuk Lymphoma
, vol.15
, pp. 143-147
-
-
Visani, G.1
Tosi, P.2
Cenacchi, A.3
Manfroi, S.4
Gamberi, B.5
Ottaviani, E.6
Tura, S.7
-
116
-
-
79960971354
-
Early onset chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL). Results of a randomized study
-
De Botton S, Coitteux V, Chevret S, Dombret H, Sanz M, San Miguel J, Caillot D, et al (2001) Early onset chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL). Results of a randomized study. Blood 98:766a
-
(2001)
Blood
, vol.98
-
-
De Botton, S.1
Coitteux, V.2
Chevret, S.3
Dombret, H.4
Sanz, M.5
San Miguel, J.6
Caillot, D.7
-
118
-
-
0028294564
-
Induction of differentiation of promyelocytic NB4 cells by retinoic acid is associated with rapid increase in urokinase activity subsequently downregulated by production of inhibitors
-
Tapiovaara H, Matikainen S, Hurme M, Vaheri A (1994) Induction of differentiation of promyelocytic NB4 cells by retinoic acid is associated with rapid increase in urokinase activity subsequently downregulated by production of inhibitors. Blood 83:1883-1891
-
(1994)
Blood
, vol.83
, pp. 1883-1891
-
-
Tapiovaara, H.1
Matikainen, S.2
Hurme, M.3
Vaheri, A.4
-
119
-
-
0027258561
-
Multiple thrombosis in acute promyelocytic leukaemia after tretinoin
-
de Lacerda JF, do Carmo JA, Guerra ML, Geraldes J, de Lacerda JM (1993) Multiple thrombosis in acute promyelocytic leukaemia after tretinoin. Lancet 342:114-115
-
(1993)
Lancet
, vol.342
, pp. 114-115
-
-
de Lacerda, J.F.1
do Carmo, J.A.2
Guerra, M.L.3
Geraldes, J.4
de Lacerda, J.M.5
-
120
-
-
0028337530
-
Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage
-
Hashimoto S, Koike T, Tatewaki W, Seki Y, Sato N, Azegami T, Tsukada N, Takahashi H, Kimura H, Ueno M, et al (1994) Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage. Leukemia 8:1113-1115
-
(1994)
Leukemia
, vol.8
, pp. 1113-1115
-
-
Hashimoto, S.1
Koike, T.2
Tatewaki, W.3
Seki, Y.4
Sato, N.5
Azegami, T.6
Tsukada, N.7
Takahashi, H.8
Kimura, H.9
Ueno, M.10
-
121
-
-
0033038544
-
Coronaric thrombotic events in acute promyelocytic leukemia during all-trans retinoic acid treatment: A role for adhesion molecules overexpression?
-
Torromeo C, Latagliata R, Avvisati G, Petti MC, Mandelli F (1999) Coronaric thrombotic events in acute promyelocytic leukemia during all-trans retinoic acid treatment: a role for adhesion molecules overexpression? Leukemia 13:312-313
-
(1999)
Leukemia
, vol.13
, pp. 312-313
-
-
Torromeo, C.1
Latagliata, R.2
Avvisati, G.3
Petti, M.C.4
Mandelli, F.5
-
122
-
-
0026580558
-
Hypercalcaemia due to all-trans retinoic acid
-
Akiyama H, Nakamura N, Nagasaka S, Sakamaki H, Onozawa Y (1992) Hypercalcaemia due to all-trans retinoic acid. Lancet 339:308-309
-
(1992)
Lancet
, vol.339
, pp. 308-309
-
-
Akiyama, H.1
Nakamura, N.2
Nagasaka, S.3
Sakamaki, H.4
Onozawa, Y.5
-
123
-
-
0027267422
-
Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia
-
Hakimian D, Tallman MS, Zugerman C, Caro WA (1993) Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Leukemia 7:758-759
-
(1993)
Leukemia
, vol.7
, pp. 758-759
-
-
Hakimian, D.1
Tallman, M.S.2
Zugerman, C.3
Caro, W.A.4
-
124
-
-
0026770410
-
Brief report: Severe symptoms of hyperhistaminemia after the treatment of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)
-
Koike T, Tatewaki W, Aoki A, Yoshimoto H, Yagisawa K, Hashimoto S, Furukawa T, Saitoh H, Takahashi M, Yang LB, et al (1992) Brief report: severe symptoms of hyperhistaminemia after the treatment of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 327:385-387
-
(1992)
N Engl J Med
, vol.327
, pp. 385-387
-
-
Koike, T.1
Tatewaki, W.2
Aoki, A.3
Yoshimoto, H.4
Yagisawa, K.5
Hashimoto, S.6
Furukawa, T.7
Saitoh, H.8
Takahashi, M.9
Yang, L.B.10
-
125
-
-
0028261220
-
Marked basophilia in acute promyelocytic leukaemia treated with all-trans retinoic acid: Molecular analysis of the cell origin of the basophils
-
Iwakiri R, Inokuchi K, Dan K, Nomura T (1994) Marked basophilia in acute promyelocytic leukaemia treated with all-trans retinoic acid: molecular analysis of the cell origin of the basophils. Br J Haematol 86:870-872
-
(1994)
Br J Haematol
, vol.86
, pp. 870-872
-
-
Iwakiri, R.1
Inokuchi, K.2
Dan, K.3
Nomura, T.4
-
126
-
-
0028774369
-
Myositis with tretinoin
-
Miranda N, Oliveira P, Frade MJ, Melo J, Marques MS, Parreira A (1994) Myositis with tretinoin. Lancet 344:1096
-
(1994)
Lancet
, vol.344
, pp. 1096
-
-
Miranda, N.1
Oliveira, P.2
Frade, M.J.3
Melo, J.4
Marques, M.S.5
Parreira, A.6
-
128
-
-
0032449676
-
Sweet's syndrome during treatment with all-trans retinoic acid in a patient with acute promyelocytic leukemia
-
Arun B, Berberian B, Azumi N, Frankel SR, Luksenburg H, Freter C (1998) Sweet's syndrome during treatment with all-trans retinoic acid in a patient with acute promyelocytic leukemia. Leuk Lymphoma 31:613-615
-
(1998)
Leuk Lymphoma
, vol.31
, pp. 613-615
-
-
Arun, B.1
Berberian, B.2
Azumi, N.3
Frankel, S.R.4
Luksenburg, H.5
Freter, C.6
-
129
-
-
0031907633
-
Fournier's gangrene during induction treatment of acute promyelocytic leukemia, a case report
-
Levy V, Jaffarbey J, Aouad K, Zittoun R (1998) Fournier's gangrene during induction treatment of acute promyelocytic leukemia, a case report. Ann Hematol 76:91-92
-
(1998)
Ann Hematol
, vol.76
, pp. 91-92
-
-
Levy, V.1
Jaffarbey, J.2
Aouad, K.3
Zittoun, R.4
-
130
-
-
0032608226
-
Scrotal ulcer occurring in patients with acute promyelocytic leukemia during treatment with all-trans retinoic acid
-
Mori A, Tamura S, Katsuno T, Nishimura Y, Itoh T, Saheki K, Takatsuka H, Wada H, Fujimori Y, Okamoto T, Takemoto Y, Kakishita E (1999) Scrotal ulcer
-
(1999)
Oncol Rep
, vol.6
, pp. 55-58
-
-
Mori, A.1
Tamura, S.2
Katsuno, T.3
Nishimura, Y.4
Itoh, T.5
Saheki, K.6
Takatsuka, H.7
Wada, H.8
Fujimori, Y.9
Okamoto, T.10
Takemoto, Y.11
Kakishita, E.12
-
131
-
-
0030900759
-
All-trans retinoic acid induced thrombocytosis in a patient with acute promyelocytic leukaemia
-
Kentos A, Le Moine F, Crenier L, Capel P, Meyer S, Muus P, Mandelli F, Feremans W (1997) All-trans retinoic acid induced thrombocytosis in a patient with acute promyelocytic leukaemia. Br J Haematol 97:685
-
(1997)
Br J Haematol
, vol.97
, pp. 685
-
-
Kentos, A.1
Le Moine, F.2
Crenier, L.3
Capel, P.4
Meyer, S.5
Muus, P.6
Mandelli, F.7
Feremans, W.8
-
132
-
-
0031868815
-
All trans retinoic acid as the possible cause of necrotizing vasculitis
-
Paydas S, Sahin B, Zorludemir S, Hazar B (1998) All trans retinoic acid as the possible cause of necrotizing vasculitis. Leuk Res 22:655-657
-
(1998)
Leuk Res
, vol.22
, pp. 655-657
-
-
Paydas, S.1
Sahin, B.2
Zorludemir, S.3
Hazar, B.4
|